EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Palmitoylethanolamide in the Treatment of Chronic Pain: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials

Kordula Lang-Illievich, Christoph Klivinyi, Christian Lasser, Connor T A Brenna iD, Istvan S Szilagyi, Helmar Bornemann-Cimenti iD

Nutrients · 10.03.2023 · 15 (6) · 1350

DOI: 10.3390/nu15061350 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Nutrients, online erschienen am 10.03.2023. Verfasst von Kordula Lang-Illievich und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology and Intensive Care Medicine, Medical University of Graz, 8036 Graz, Austria. Hauptthemen laut MEDLINE: Chronic Pain. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic pain is a major source of morbidity for which there are limited effective treatments. Palmitoylethanolamide (PEA), a naturally occurring fatty acid amide, has demonstrated utility in the treatment of neuropathic and inflammatory pain. Emerging reports have supported a possible role for its use in the treatment of chronic pain, although this remains controversial. We undertook a systematic review and meta-analysis to examine the efficacy of PEA as an analgesic agent for chronic pain. A systematic literature search was performed, using the databases MEDLINE and Web of Science, to identify double-blind randomized controlled trials comparing PEA to placebo or active comparators in the treatment of chronic pain. All articles were independently screened by two reviewers. The primary outcome was pain intensity scores, for which a meta-analysis was undertaken using a random effects statistical model. Secondary outcomes including quality of life, functional status, and side effects are represented in a narrative synthesis. Our literature search identified 253 unique articles, of which 11 were ultimately included in the narrative synthesis and meta-analysis. Collectively, these articles described a combined sample size of 774 patients. PEA was found to reduce pain scores relative to comparators in a pooled estimate, with a standard mean difference of 1.68 (95% CI 1.05 to 2.31, p = 0.00001). Several studies reported additional benefits of PEA for quality of life and functional status, and no major side effects were attributed to PEA in any study. The results of this systematic review and meta-analysis suggest that PEA is an effective and well-tolerated treatment for chronic pain. Further study is warranted to determine the optimal dosing and administration parameters of PEA for analgesic effects in the context of chronic pain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chronic PainHumansQuality of LifeRandomized Controlled Trials as TopicAnalgesicsAmidesEthanolaminesPalmitic Acids

Stichwörter der Autor:innen

ImpulsinN-(2hydroxyethyl)-palmitamidePalmidrolanalgesiachronic painpalmitoylethanolamidequality of life

Substanzen

AnalgesicsAmidespalmidrolEthanolaminesPalmitic Acids

Autor:innen und Institutionen

  • Department of Anaesthesiology and Intensive Care Medicine, Medical University of Graz, 8036 Graz, Austria.
  • Department of Anesthesiology & Pain Medicine, University of Toronto, Toronto, ON M5S 1A1, Canada.
  • Division of Medical Psychology, Psychosomatics and Psychotherapeutic Medicine, Department of Psychiatry, Psychosomatics and Psychotherapeutic Medicine, Medical University of Graz, 8036 Graz, Austria.

ORCID-Profile: Connor T A Brenna, Helmar Bornemann-Cimenti

Zitieren

APA

Lang-Illievich, K., Klivinyi, C., Lasser, C., Brenna, C. T. A., Szilagyi, I. S., & Bornemann-Cimenti, H. (2023). Palmitoylethanolamide in the Treatment of Chronic Pain: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials. Nutrients, 15(6), 1350. https://doi.org/10.3390/nu15061350

Vancouver

Lang-Illievich K, Klivinyi C, Lasser C, Brenna CTA, Szilagyi IS, Bornemann-Cimenti H. Palmitoylethanolamide in the Treatment of Chronic Pain: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials. Nutrients. 2023;15(6):1350. doi:10.3390/nu15061350

BibTeX
@article{LangIllievich2023,
  author = {Lang-Illievich, Kordula and Klivinyi, Christoph and Lasser, Christian and Brenna, Connor T A and Szilagyi, Istvan S and Bornemann-Cimenti, Helmar},
  title = {Palmitoylethanolamide in the Treatment of Chronic Pain: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials},
  journal = {Nutrients},
  year = {2023},
  volume = {15},
  number = {6},
  pages = {1350},
  doi = {10.3390/nu15061350}
}
Kostenlos starten →